4/4
08:04 am
cgon
CG Oncology, Inc. (NASDAQ: CGON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
Low
Report
CG Oncology, Inc. (NASDAQ: CGON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
2/20
09:07 am
cgon
Rating for CGON
Medium
Report
Rating for CGON
2/20
07:29 am
cgon
CG Oncology, Inc. (NASDAQ: CGON) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $75.00 price target on the stock.
Medium
Report
CG Oncology, Inc. (NASDAQ: CGON) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $75.00 price target on the stock.
2/20
07:23 am
cgon
CG Oncology initiated with bullish view at Cantor Fitzgerald
Medium
Report
CG Oncology initiated with bullish view at Cantor Fitzgerald
2/20
07:17 am
cgon
CG Oncology, Inc. (NASDAQ: CGON) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $55.00 price target on the stock.
Medium
Report
CG Oncology, Inc. (NASDAQ: CGON) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $55.00 price target on the stock.
2/20
07:17 am
cgon
CG Oncology, Inc. (NASDAQ: CGON) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $55.00 price target on the stock.
Medium
Report
CG Oncology, Inc. (NASDAQ: CGON) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $55.00 price target on the stock.
2/20
07:17 am
cgon
CG Oncology, Inc. (NASDAQ: CGON) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $55.00 price target on the stock.
Medium
Report
CG Oncology, Inc. (NASDAQ: CGON) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $55.00 price target on the stock.
2/20
07:17 am
cgon
CG Oncology, Inc. (NASDAQ: CGON) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $55.00 price target on the stock.
Medium
Report
CG Oncology, Inc. (NASDAQ: CGON) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $55.00 price target on the stock.
2/20
05:30 am
cgon
Rating for CGON
Medium
Report
Rating for CGON
2/20
05:30 am
cgon
Rating for CGON
Medium
Report
Rating for CGON
2/20
05:30 am
cgon
Rating for CGON
Medium
Report
Rating for CGON
2/20
05:25 am
cgon
Rating for CGON
Medium
Report
Rating for CGON
2/20
05:25 am
cgon
Rating for CGON
Medium
Report
Rating for CGON
2/14
07:10 am
cgon
CG Oncology, Inc. (NASDAQ: CGON) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $75.00 price target on the stock.
Low
Report
CG Oncology, Inc. (NASDAQ: CGON) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $75.00 price target on the stock.